Secure CheckoutPersonal information is secured with SSL technology.
Free ShippingFree global shipping
No minimum order.
Drug Delivery Aspects reviews additional features of drug delivery systems, along with the standard formulation development, like preclinical testing, conversion into solid dosage forms, roles of excipients and polymers used on stability and sterile processing. There is a focus on formulation engineering and related large scale (GMP) manufacturing, regulatory, and functional aspects of drug delivery systems. A detailed discussion on biologics and vaccines gives insights to readers on new developments in this direction.
The series Expectations and Realities of Multifunctional Drug Delivery Systems examines the fabrication, optimization, biological aspects, regulatory and clinical success of wide range of drug delivery carriers. This series reviews multifunctionality and applications of drug delivery systems, industrial trends, regulatory challenges and in vivo success stories. Throughout the volumes discussions on diverse aspects of drug delivery carriers, such as clinical, engineering, and regulatory, facilitate insight sharing across expertise area and form a link for collaborations between industry-academic scientists and clinical researchers.
Expectations and Realities of Multifunctional Drug Delivery Systems connects formulation scientists, regulatory experts, engineers, clinical experts and regulatory stake holders. The wide scope of the book ensures it as a valuable reference resource for researchers in both academia and the pharmaceutical industry who want to learn more about drug delivery systems.
Encompasses engineering and large-scale manufacturing of nanocarriers
Considers preclinical, regulatory and ethical guidelines on nanoparticles
Contains in-depth discussions on delivery of biologics, vaccines and sterilisation
Industrial view on solid dispersions, milling techniques
Other volumes in the Expectations and Realities of Multifunctional Drug Delivery Systems book series:
Nanopharmaceuticals, Volume 1, 9780128177785
Delivery of Drugs, Volume 2, 9780128177761
Drug Delivery Trends: Volume 3, 9780128178706
Pharmaceutical Scientists in academia and industry; pharmacologists; regulatory experts; bioengineers
- Versatile hyaluronic acid nanoparticles for improved drug delivery
Mona M.A. Abdel-Mottaleb, Hend Abd-Allah, Riham I. El-Gogary, and Maha Nasr
2. Preclinical testing—Understanding the basics first
3. Aqueous polymeric coatings: New opportunities in drug delivery systems
Abid Riaz Ahmed, Joana Portugal Mota, Ahmad Abdul-Wahhab Shahba, and Muhammad Irfan
4. Large-scale manufacturing of nanoparticles—An industrial outlook
Ranjita Shegokar and Mostafa Nakach
5. The role of polymers and excipients in developing amorphous solid dispersions: An industrial perspective
Vaibhav Sihorkar and Thomas Durig
6. Biologics: Delivery options and formulation development strategies
Ridahunlang Nongkhlaw, Parameswar Patra, Akash Chavrasiya, Nirmal Jayabalan, and Sachin Dubey
7. The regulatory and ethical issues in nanoparticles, materials and particles (NMP) research
J. Dias-Ferreira, Ranjita Shegokar, A. Santini, and E.B. Souto
8. Sterile procedures for pharmaceutical dosage forms
Sarabjit Singh and Dharmesh Mehta
9. Vaccine delivery strategies against botulism
Yongyong Yan, Diana Diaz-Arevalo, Haiyan Wang, Yanping Chen, and Mingtao Zeng
10. Nanotechnological approaches for delivery of antiinflammatory drugs
Anđelka B. Kovacevic
11. Food to medicine transformation of stilbenoid vesicular and lipid-based nanocarriers: Technological advances
Sara M. Abdel Samie and Maha Nasr
- No. of pages:
- © Elsevier 2020
- 30th March 2020
- Paperback ISBN:
- eBook ISBN:
Dr. Ranjita Shegokar holds a PhD degree in Pharmaceutical Technology from the SNDT University, India, and has been postdoctoral researcher in the Department of Pharmaceutics, Biopharmaceutics and NutriCosmetics at Free University of Berlin, Germany. Since last 8 years she is working in the pharmaceutical industry in various technical/R&D roles. Currently, she serves as Director of Pharma Business Unit at Capnomed GmbH, Germany. She has authored many research articles, book chapters, and presented several research papers in conferences. She has filed multiple patent application in area of drug delivery and drug targeting. She received several national and international awards for her research. Her areas of interest include polymeric nanoparticles, nanocrystals, lipid nanoparticles (SLNs/NLCs), nanoemulsions and role of excipients in delivery systems.
Director, Pharma Business Unit, Capnomed GmbH, Germany
Elsevier.com visitor survey
We are always looking for ways to improve customer experience on Elsevier.com.
We would like to ask you for a moment of your time to fill in a short questionnaire, at the end of your visit.
If you decide to participate, a new browser tab will open so you can complete the survey after you have completed your visit to this website.
Thanks in advance for your time.